Loading…
Symptom scores and medication treatment patterns in children with ADHD versus autism
•Psychotropic use was analyzed in 1407 children with autism and 1036 with ADHD.•Symptom scores for medicated children were far higher than for unmedicated children.•Percent prescribed a psychotropic did not differ between ADHD-Combined and autism.•Children with ADHD-Inattentive were least impaired a...
Saved in:
Published in: | Psychiatry research 2020-06, Vol.288, p.112937-112937, Article 112937 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3 |
container_end_page | 112937 |
container_issue | |
container_start_page | 112937 |
container_title | Psychiatry research |
container_volume | 288 |
creator | Mayes, Susan D. Waxmonsky, James G. Baweja, Raman Mattison, Richard E. Memon, Hasan Klein, Melanie Hameed, Usman Waschbusch, Daniel |
description | •Psychotropic use was analyzed in 1407 children with autism and 1036 with ADHD.•Symptom scores for medicated children were far higher than for unmedicated children.•Percent prescribed a psychotropic did not differ between ADHD-Combined and autism.•Children with ADHD-Inattentive were least impaired and least likely to be medicated.•Medication classes prescribed differed between ADHD and autism.
Most children with autism have ADHD, and children with ADHD-Combined and children with autism have high rates of irritable, oppositional, and aggressive behavior. Despite similar symptoms, prescribing practices may differ between autism and ADHD, which has not been examined in a single study. 1407 children with autism and 1036 with ADHD without autism, 2–17 years, were compared with 186 typical peers. Symptom scores were maternal Pediatric Behavior Scale ratings in eight areas (ADHD, oppositional/aggressive, irritable/angry, anxious, depressed, and social, writing, and learning problems). Psychotropics were prescribed to 38.0% with ADHD-Combined, 33.3% with autism, and 20.2% with ADHD-Inattentive, most often an ADHD medication (22.1% stimulant, 2.3% atomoxetine), antipsychotic (7.8%), SSRI (5.5%), and alpha agonist (4.9%). ADHD medications were more often prescribed than other medications in all diagnostic groups. Compared to autism, children with ADHD-Combined were more likely to be prescribed an ADHD medication, whereas antipsychotics and SSRIs were more likely to be prescribed in autism than in ADHD-Combined. Children with ADHD-Inattentive were least impaired and least likely to be medicated. More severely impaired children were more often medicated regardless of diagnosis. Symptom scores were far worse for treated and untreated children with ADHD and with autism than for typical peers. |
doi_str_mv | 10.1016/j.psychres.2020.112937 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2393638578</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165178119321444</els_id><sourcerecordid>2393638578</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3</originalsourceid><addsrcrecordid>eNqFkE1PAjEQhhujEUT_AunRy-K23d12bxJQMSHxIJ6b0p0NJftl28Xw7y1Z8Oplmkyed2b6IDQl8YzEJHvazzp31DsLbkZjGpqE5oxfoTERnEacUHaNxgFMI8IFGaE75_ZxHFOS57doxCgjqeDZGG0-j3Xn2xo73YZhWDUFrqEwWnnTNthbUL6GxuNOeQ-2cdg0WO9MVVho8I_xOzxfrpb4ANb1Id574-p7dFOqysHD-Z2gr9eXzWIVrT_e3hfzdaRZJnxUlEKHk4QAliahago0p6IkRSqyhFAtgPBtlqsSOMlVkpWpzgUHJhQpRVKwCXoc5na2_e7BeVkbp6GqVANt7yRlOcuYSLkIaDag2rbOWShlZ02t7FGSWJ6Myr28GJUno3IwGoLT845-G8T8xS4KA_A8ABB-ejBgpdMGGh0kWtBeFq35b8cv6h2LVQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2393638578</pqid></control><display><type>article</type><title>Symptom scores and medication treatment patterns in children with ADHD versus autism</title><source>ScienceDirect Freedom Collection</source><creator>Mayes, Susan D. ; Waxmonsky, James G. ; Baweja, Raman ; Mattison, Richard E. ; Memon, Hasan ; Klein, Melanie ; Hameed, Usman ; Waschbusch, Daniel</creator><creatorcontrib>Mayes, Susan D. ; Waxmonsky, James G. ; Baweja, Raman ; Mattison, Richard E. ; Memon, Hasan ; Klein, Melanie ; Hameed, Usman ; Waschbusch, Daniel</creatorcontrib><description>•Psychotropic use was analyzed in 1407 children with autism and 1036 with ADHD.•Symptom scores for medicated children were far higher than for unmedicated children.•Percent prescribed a psychotropic did not differ between ADHD-Combined and autism.•Children with ADHD-Inattentive were least impaired and least likely to be medicated.•Medication classes prescribed differed between ADHD and autism.
Most children with autism have ADHD, and children with ADHD-Combined and children with autism have high rates of irritable, oppositional, and aggressive behavior. Despite similar symptoms, prescribing practices may differ between autism and ADHD, which has not been examined in a single study. 1407 children with autism and 1036 with ADHD without autism, 2–17 years, were compared with 186 typical peers. Symptom scores were maternal Pediatric Behavior Scale ratings in eight areas (ADHD, oppositional/aggressive, irritable/angry, anxious, depressed, and social, writing, and learning problems). Psychotropics were prescribed to 38.0% with ADHD-Combined, 33.3% with autism, and 20.2% with ADHD-Inattentive, most often an ADHD medication (22.1% stimulant, 2.3% atomoxetine), antipsychotic (7.8%), SSRI (5.5%), and alpha agonist (4.9%). ADHD medications were more often prescribed than other medications in all diagnostic groups. Compared to autism, children with ADHD-Combined were more likely to be prescribed an ADHD medication, whereas antipsychotics and SSRIs were more likely to be prescribed in autism than in ADHD-Combined. Children with ADHD-Inattentive were least impaired and least likely to be medicated. More severely impaired children were more often medicated regardless of diagnosis. Symptom scores were far worse for treated and untreated children with ADHD and with autism than for typical peers.</description><identifier>ISSN: 0165-1781</identifier><identifier>EISSN: 1872-7123</identifier><identifier>DOI: 10.1016/j.psychres.2020.112937</identifier><identifier>PMID: 32315876</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>ADHD-Combined ; ADHD-Inattentive ; Psychotropic medication ; Symptom profiles</subject><ispartof>Psychiatry research, 2020-06, Vol.288, p.112937-112937, Article 112937</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3</citedby><cites>FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32315876$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mayes, Susan D.</creatorcontrib><creatorcontrib>Waxmonsky, James G.</creatorcontrib><creatorcontrib>Baweja, Raman</creatorcontrib><creatorcontrib>Mattison, Richard E.</creatorcontrib><creatorcontrib>Memon, Hasan</creatorcontrib><creatorcontrib>Klein, Melanie</creatorcontrib><creatorcontrib>Hameed, Usman</creatorcontrib><creatorcontrib>Waschbusch, Daniel</creatorcontrib><title>Symptom scores and medication treatment patterns in children with ADHD versus autism</title><title>Psychiatry research</title><addtitle>Psychiatry Res</addtitle><description>•Psychotropic use was analyzed in 1407 children with autism and 1036 with ADHD.•Symptom scores for medicated children were far higher than for unmedicated children.•Percent prescribed a psychotropic did not differ between ADHD-Combined and autism.•Children with ADHD-Inattentive were least impaired and least likely to be medicated.•Medication classes prescribed differed between ADHD and autism.
Most children with autism have ADHD, and children with ADHD-Combined and children with autism have high rates of irritable, oppositional, and aggressive behavior. Despite similar symptoms, prescribing practices may differ between autism and ADHD, which has not been examined in a single study. 1407 children with autism and 1036 with ADHD without autism, 2–17 years, were compared with 186 typical peers. Symptom scores were maternal Pediatric Behavior Scale ratings in eight areas (ADHD, oppositional/aggressive, irritable/angry, anxious, depressed, and social, writing, and learning problems). Psychotropics were prescribed to 38.0% with ADHD-Combined, 33.3% with autism, and 20.2% with ADHD-Inattentive, most often an ADHD medication (22.1% stimulant, 2.3% atomoxetine), antipsychotic (7.8%), SSRI (5.5%), and alpha agonist (4.9%). ADHD medications were more often prescribed than other medications in all diagnostic groups. Compared to autism, children with ADHD-Combined were more likely to be prescribed an ADHD medication, whereas antipsychotics and SSRIs were more likely to be prescribed in autism than in ADHD-Combined. Children with ADHD-Inattentive were least impaired and least likely to be medicated. More severely impaired children were more often medicated regardless of diagnosis. Symptom scores were far worse for treated and untreated children with ADHD and with autism than for typical peers.</description><subject>ADHD-Combined</subject><subject>ADHD-Inattentive</subject><subject>Psychotropic medication</subject><subject>Symptom profiles</subject><issn>0165-1781</issn><issn>1872-7123</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkE1PAjEQhhujEUT_AunRy-K23d12bxJQMSHxIJ6b0p0NJftl28Xw7y1Z8Oplmkyed2b6IDQl8YzEJHvazzp31DsLbkZjGpqE5oxfoTERnEacUHaNxgFMI8IFGaE75_ZxHFOS57doxCgjqeDZGG0-j3Xn2xo73YZhWDUFrqEwWnnTNthbUL6GxuNOeQ-2cdg0WO9MVVho8I_xOzxfrpb4ANb1Id574-p7dFOqysHD-Z2gr9eXzWIVrT_e3hfzdaRZJnxUlEKHk4QAliahago0p6IkRSqyhFAtgPBtlqsSOMlVkpWpzgUHJhQpRVKwCXoc5na2_e7BeVkbp6GqVANt7yRlOcuYSLkIaDag2rbOWShlZ02t7FGSWJ6Myr28GJUno3IwGoLT845-G8T8xS4KA_A8ABB-ejBgpdMGGh0kWtBeFq35b8cv6h2LVQ</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Mayes, Susan D.</creator><creator>Waxmonsky, James G.</creator><creator>Baweja, Raman</creator><creator>Mattison, Richard E.</creator><creator>Memon, Hasan</creator><creator>Klein, Melanie</creator><creator>Hameed, Usman</creator><creator>Waschbusch, Daniel</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202006</creationdate><title>Symptom scores and medication treatment patterns in children with ADHD versus autism</title><author>Mayes, Susan D. ; Waxmonsky, James G. ; Baweja, Raman ; Mattison, Richard E. ; Memon, Hasan ; Klein, Melanie ; Hameed, Usman ; Waschbusch, Daniel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>ADHD-Combined</topic><topic>ADHD-Inattentive</topic><topic>Psychotropic medication</topic><topic>Symptom profiles</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mayes, Susan D.</creatorcontrib><creatorcontrib>Waxmonsky, James G.</creatorcontrib><creatorcontrib>Baweja, Raman</creatorcontrib><creatorcontrib>Mattison, Richard E.</creatorcontrib><creatorcontrib>Memon, Hasan</creatorcontrib><creatorcontrib>Klein, Melanie</creatorcontrib><creatorcontrib>Hameed, Usman</creatorcontrib><creatorcontrib>Waschbusch, Daniel</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Psychiatry research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mayes, Susan D.</au><au>Waxmonsky, James G.</au><au>Baweja, Raman</au><au>Mattison, Richard E.</au><au>Memon, Hasan</au><au>Klein, Melanie</au><au>Hameed, Usman</au><au>Waschbusch, Daniel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Symptom scores and medication treatment patterns in children with ADHD versus autism</atitle><jtitle>Psychiatry research</jtitle><addtitle>Psychiatry Res</addtitle><date>2020-06</date><risdate>2020</risdate><volume>288</volume><spage>112937</spage><epage>112937</epage><pages>112937-112937</pages><artnum>112937</artnum><issn>0165-1781</issn><eissn>1872-7123</eissn><abstract>•Psychotropic use was analyzed in 1407 children with autism and 1036 with ADHD.•Symptom scores for medicated children were far higher than for unmedicated children.•Percent prescribed a psychotropic did not differ between ADHD-Combined and autism.•Children with ADHD-Inattentive were least impaired and least likely to be medicated.•Medication classes prescribed differed between ADHD and autism.
Most children with autism have ADHD, and children with ADHD-Combined and children with autism have high rates of irritable, oppositional, and aggressive behavior. Despite similar symptoms, prescribing practices may differ between autism and ADHD, which has not been examined in a single study. 1407 children with autism and 1036 with ADHD without autism, 2–17 years, were compared with 186 typical peers. Symptom scores were maternal Pediatric Behavior Scale ratings in eight areas (ADHD, oppositional/aggressive, irritable/angry, anxious, depressed, and social, writing, and learning problems). Psychotropics were prescribed to 38.0% with ADHD-Combined, 33.3% with autism, and 20.2% with ADHD-Inattentive, most often an ADHD medication (22.1% stimulant, 2.3% atomoxetine), antipsychotic (7.8%), SSRI (5.5%), and alpha agonist (4.9%). ADHD medications were more often prescribed than other medications in all diagnostic groups. Compared to autism, children with ADHD-Combined were more likely to be prescribed an ADHD medication, whereas antipsychotics and SSRIs were more likely to be prescribed in autism than in ADHD-Combined. Children with ADHD-Inattentive were least impaired and least likely to be medicated. More severely impaired children were more often medicated regardless of diagnosis. Symptom scores were far worse for treated and untreated children with ADHD and with autism than for typical peers.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>32315876</pmid><doi>10.1016/j.psychres.2020.112937</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0165-1781 |
ispartof | Psychiatry research, 2020-06, Vol.288, p.112937-112937, Article 112937 |
issn | 0165-1781 1872-7123 |
language | eng |
recordid | cdi_proquest_miscellaneous_2393638578 |
source | ScienceDirect Freedom Collection |
subjects | ADHD-Combined ADHD-Inattentive Psychotropic medication Symptom profiles |
title | Symptom scores and medication treatment patterns in children with ADHD versus autism |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T23%3A03%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Symptom%20scores%20and%20medication%20treatment%20patterns%20in%20children%20with%20ADHD%20versus%20autism&rft.jtitle=Psychiatry%20research&rft.au=Mayes,%20Susan%20D.&rft.date=2020-06&rft.volume=288&rft.spage=112937&rft.epage=112937&rft.pages=112937-112937&rft.artnum=112937&rft.issn=0165-1781&rft.eissn=1872-7123&rft_id=info:doi/10.1016/j.psychres.2020.112937&rft_dat=%3Cproquest_cross%3E2393638578%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c368t-df8c00288e35488ec2e2928f1d586412c8e17b69afe719a46f5c987e38a1f84d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2393638578&rft_id=info:pmid/32315876&rfr_iscdi=true |